Moreover, the spectrum of NRAS mutations differed between both CBF leukemias, and exon 61 mutations were more frequently observed in CBFB/MYH11 AMLs (i.e., harboring inv(16) or t(16;16)). This evidence concerns the gene NRAS and leukemia.